With a market cap of $218.8 billion, Abbott Laboratories (ABT) is a global healthcare leader with a diversified portfolio ...

Abbott (ABT) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

Key Insights Significantly high institutional ownership implies Abbott Laboratories' stock price is sensitive to ...

Abbott Laboratories has won a legal case claiming its Similac infant formula caused the death of a baby from necrotizing ...

The win is Abbott’s third in a row in federal court in Chicago where hundreds of cases over specialized formulas for preterm infants have been consolidated.

Abbott Laboratories Inc. convinced a federal judge that there wasn’t a feasible alternative design to a form of infant formula that parents said caused a fatal disease to their preterm child.

Abbott Laboratories (NYSE:ABT) is preparing to release its quarterly earnings on Thursday, 2025-07-17. Here's a brief overview of what investors should keep in mind before the announcement. Analysts ...

The fate of hundreds of pending cases against Abbott and Mead Johnson hang in the balance with the latest dismissal.

Abbott Laboratories (NYSE:ABT) has significantly outperformed the broader S&P 500 index this year, with its stock price rising 18% compared to the S&P 500’s 6% gain. This strong performance stems from ...

The court said D.B.'s parents could not meet the threshold for a product liability claim under Louisiana's Products Liability ...

Medical products maker Abbott Laboratories worked to buoy investor confidence Wednesday as it announced that tariffs are expected to create a financial impact in the hundreds of millions of dollars, ...